Gene expressions and copy numbers in cervical cancer
Author Information
Author(s): Lyng Heidi, Brøvig Runar S, Svendsrud Debbie H, Holm Ruth, Kaalhus Olav, Knutstad Kjetil, Oksefjell Halldis, Sundfør Kolbein, Kristensen Gunnar B, Stokke Trond
Primary Institution: Health Enterprise Rikshospitalet – Radiumhospitalet, Oslo, Norway
Hypothesis
This study aims to identify gene expressions associated with metastatic phenotypes of locally advanced cervical carcinomas.
Conclusion
The study identified gene expressions associated with metastatic phenotypes of cervical cancers, which may serve as markers for cancer spread.
Supporting Evidence
- Thirty-one genes that differed in expression between node positive and negative tumors were identified.
- Expressions of eight genes correlated with progression free survival.
- Multivariate analysis identified tumor volume and PDK2 expression as independent prognostic variables.
Takeaway
Researchers looked at genes in cervical cancer to see which ones are linked to spreading the disease, finding some that could help doctors understand and treat it better.
Methodology
Gene expressions and copy number changes were determined in primary tumors from patients using cDNA and genomic microarray techniques.
Potential Biases
Potential bias due to the small sample size and the specific patient population studied.
Limitations
The study's conclusions are based on a limited number of patients, which may affect the generalizability of the findings.
Participant Demographics
Patients with primary squamous cell carcinoma of the uterine cervix, diagnosed between 2001 and 2004.
Statistical Information
P-Value
p<0.0001 for tumor volume; p=0.0001 for MRPL11 expression
Confidence Interval
1.01 – 1.02 for tumor volume
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website